Intramyocardial Injection of Autologous Umbilical Cord Blood Derived Mononuclear Cells During Surgical Repair of Hypoplastic Left Heart Syndrome

NCT03779711 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

95

Enrollment

OTHER

Sponsor class

Conditions

Hypoplastic Left Heart Syndrome

Interventions

BIOLOGICAL: Autologous (self) mononuclear cells derived from umbilical cord blood
PROCEDURE: Stage II Surgical repair

Sponsor

Timothy J Nelson, MD, PhD

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]